Harvard Bioscience, Inc. - Common Stock — Informes financieros (NASDAQ:HBIO)

Harvard Bioscience, Inc. - Common Stock

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.

HBIO

Financials

Harvard Bioscience, Inc. - Common Stock

Noticias

Informe de resultados de Harvard Bioscience en el Q1 2026: BPA por debajo de previsiones y caída de la acción

El director de Harvard Bioscience Snider compra acciones de HBIO por 103.603 dólares

Benchmark eleva el precio objetivo de Harvard Bioscience a 6 dólares

Benchmark eleva precio objetivo de Harvard Bioscience a $6 tras split inverso

Benchmark raises Harvard Bioscience stock price target to $6 on reverse split

Benchmark reduce el precio objetivo de Harvard Bioscience por preocupaciones sobre el NIH

Benchmark recorta precio objetivo de Harvard Bioscience por inquietudes NIH

Benchmark cuts Harvard Bioscience stock price target on NIH concerns

Harvard Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2026-03-13

Harvard Bioscience T4 2025: márgenes alcanzan un máximo en 7 trimestres

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high

Harvard Bioscience se quedan por debajo de 0.10$ las previsiones de BPA en el primer trimestre del año